EFFECTOR THERAPEUTICS INC (EFTR)
US28202V2079 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to EFTR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.22. This target is 493.65% above the current price.
EFTR was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about EFTR.
In the previous month the buy percentage consensus was at a similar level.
EFTR was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-24 | HC Wainwright & Co. | Initiate | Buy |
| 2023-05-26 | Stifel | Upgrade | Hold -> Buy |
| 2023-05-10 | Credit Suisse | Maintains | Outperform |
| 2023-03-09 | Credit Suisse | Maintains | Outperform |
| 2023-01-09 | JMP Securities | Maintains | Market Outperform |
| 2023-01-06 | Credit Suisse | Maintains | Outperform |
| 2022-11-17 | JMP Securities | Maintains | Market Outperform |
| 2022-08-11 | JMP Securities | Maintains | Market Outperform |
| 2022-01-25 | JMP Securities | Maintains | Market Outperform |
| 2022-01-25 | Stifel | Downgrade | Buy -> Hold |
| 2022-01-25 | Credit Suisse | Maintains | Outperform |
| 2021-11-09 | Stifel | Upgrade | Hold -> Buy |
| 2021-10-12 | Credit Suisse | Initiate | Outperform |
| 2021-10-04 | Mizuho | Initiate | Buy |
| 2021-09-21 | JMP Securities | Initiate | Market Outperform |
| 2021-09-20 | Stifel | Initiate | Hold |
| 2021-09-13 | Cantor Fitzgerald | Initiate | Overweight |